IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency

NCT00228852 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

T-Cell Immune Deficiency Diseases
Severe Combined Immunodeficiency

Interventions

DRUG: Busulfan, Fludarabine and ATG

Sponsor

Emory University